Skip to main content
TrendingNews.today
World News
S&P 500 5,142.30 ▲ +0.87%|NASDAQ 16,284.75 ▲ +1.12%|DOW 38,972.10 ▼ -0.23%|AAPL $192.45 ▲ +1.80%|TSLA $241.80 ▼ -2.10%|AMZN $178.92 ▲ +0.54%|GOOGL $141.20 ▲ +0.32%|MSFT $415.60 ▼ -0.15%|
S&P 500 5,142.30 ▲ +0.87%|NASDAQ 16,284.75 ▲ +1.12%|DOW 38,972.10 ▼ -0.23%|AAPL $192.45 ▲ +1.80%|TSLA $241.80 ▼ -2.10%|AMZN $178.92 ▲ +0.54%|GOOGL $141.20 ▲ +0.32%|MSFT $415.60 ▼ -0.15%|
As of Mar 31
Business1 sourcesNeutral

Galapagos And Gilead Enter Into Binding Agreement To Collaborate On Advancing First In Class T Cell Engager Program For Autoimmune Diseases

(MENAFN - GlobeNewsWire - Nasdaq) New collaboration structure achieves meaningfully improved financial terms and flexibility for Galapagos Following this transaction, the Company will continue ...

Menafn
via Menafn
ShareRead original

Read the full article at Menafn →

Source Verification

Corroboration Score: 1

This story was independently reported by 1 sources. Click any source to read the original article.

Menafn
Menafn
NewsData

Comments

0 comments
Be respectful and constructive.
Loading comments...
Previous
Robert F. Kennedy Jr. stops in Miami to announce healthy hospital menu initiative
Next
“Fallout” Season 2 Full Numbers Are In

Related Articles

Business confidence collapses as Iran war drags onBusiness
Business confidence collapses as Iran war drags on
Unknown-3h ago-1 sources
FactSet Research Boosts FY26 Outlook; Stock Up 5.6% - UpdateBusiness
FactSet Research Boosts FY26 Outlook; Stock Up 5.6% - Update
Unknown-3h ago-1 sources
Scholar Rock Holding Resubmits Apitegromab BLA To US FDA, Stock Up In Pre-MarketBusiness
Scholar Rock Holding Resubmits Apitegromab BLA To US FDA, Stock Up In Pre-Market
Unknown-3h ago-1 sources